A pragmatic, multicentre, double-blind, placebocontrolled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

Autor: Banerjee, Sube, Farina, Nicolas, Henderson, Catherine, High, Juliet, Stirling, Susan, Shepstone, Lee, Fountain, Julia, Ballard, Clive, Bentham, Peter, Burns, Alistair, Fox, Chris, Francis, Paul, Howard, Robert, Knapp, Martin, Leroi, Iracema, Livingston, Gill, Nilforooshan, Ramin, Nurock, Shirley, O'Brien, John, Price, Annabel
Zdroj: Health Technology Assessment; 10/31/2023, Vol. 27 Issue 23/24, pvii-108, 116p
Databáze: Complementary Index